Literature DB >> 27434877

The structural alteration and aggregation propensity of glycated lens crystallins in the presence of calcium: Importance of lens calcium homeostasis in development of diabetic cataracts.

Sara Zafaranchi Zm1, Kazem Khoshaman1, Raheleh Masoudi2, Bahram Hemmateenejad3, Reza Yousefi4.   

Abstract

The imbalance of the calcium homeostasis in the lenticular tissues of diabetic patients is an important risk factor for development of cataract diseases. In the current study, the impact of elevated levels of calcium ions were investigated on structure and aggregation propensity of glycated lens crystallins using gel electrophoresis and spectroscopic assessments. The glycated proteins indicated significant resistance against calcium-induced structural insults and aggregation. While, glycated crystallins revealed an increased conformational stability; a slight instability was observed for these proteins upon interaction with calcium ions. Also, in the presence of calcium, the proteolytic pattern of native crystallins was altered and that of glycated protein counterparts remained almost unchanged. According to results of this study it is suggested that the structural alteration of lens crystallins upon glycation may significantly reduce their calcium buffering capacity in eye lenses. Therefore, under chronic hyperglycemia accumulation of this cataractogenic metal ion in the lenticular tissues may subsequently culminate in activation of different pathogenic pathways, leading to development of lens opacity and cataract diseases.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregation; Calcium; Cataract; Diabetes; Lens crystallins

Mesh:

Substances:

Year:  2016        PMID: 27434877     DOI: 10.1016/j.saa.2016.07.017

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Downregulation of SMP30 in senescent human lens epithelial cells.

Authors:  Shuning Li; Xi Chen; Weixia Lai; Meixia Hu; Xin Zhong; Shaojian Tan; Hao Liang
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.